. - /

- , - - .

1/3 Doyle et al, Clinical Radiology 2009

Doyle et al, Clinical Radiology 2009

-

1

1 ,

.

Ventura et al Natl. Vital.Stat.Rep 1999

H 1 / 1.000

Litton et al, 2009 Drife In: OBrien and McLean 2000

H 1 / 3.000- 6.000 Jacobs et al 2004 Drife In: OBrien and McLean 2000 Lambe and Ekbom BMJ 1995

- ( )

Ronsmans et al 2004

Wallack et al, 0,2% - 3,8%

: 1991-1997 1,3 10.000 Smith et al, Am J Obstet Gynecol 2001

, 30 , 10-20% , . Noyes et al, Cancer 1982

* * .

3 - 10 , . Wohlfahrt et al, Am J Epidemiol 2001 Albrektsen et al, Cancer Causes Control 1996 Lambe et al, N Engl J Med 1994

A BRCA 1 & 2 Wohlfahrt et al, Am J Epidemiol 2001

BRCA2, , . Cullinane et al, Int J Cancer 2005

, , .

Guinne et al, Lancet 1994 Olson et al, Epidemiology 1998

O .

CEMACH Confidential Enquiry into Maternal and Child Health Lewis et al 2007 ,

. , , . . Collins et al, J Reprod Med, 1995

, 2 .

, 80% , . Collins et al, J Reprod Med, 1995 yrd et al, Ann Surg 1962

: . , 0,4 cGy. > 5 cGy

():

, 63 78%

Nicklas et Baker, Semin Oncol 2000 Samuels et al, Can Assoc Radiol J 1998 Liberman et al, Radiology 1994 Ishida et al, JPn J Cancer Res 1992

():

(): . HPA, RCR, CoR 2009 Orecchia et al In: Cancer and pregnancy 2008

(): H . Doyle et al, Clinical Radiology 2009

():

, . 2 4 . .

Ahn et al, J Ultrasound Med 2003

(): () , * * ,

(): () , . . (), . .

trocard

():Pet Scan Pet Scan , Zanotti-Fregonara et al J Nucl Med 2008

: + + ( ) + +

ER(-) Li et al J Clin Oncol 21:28-34,2003 Ring et al: J of Clinical Oncology Vol. 23: 2005 Li CI et al: J Clin Oncol 21:28-34, 2003 Bonnier P et al: Int J Cancer 72:720-727, 1997 Ishida T et al: Jpn J. Cancer Res 83:1143-1149, 1992

Kroman . 2 , , 1,58% (95% CI: 1.24-22.02) Kroman et al, Lancet 1997

IVF & (1986- 2003 ) Pappo et al Ann Surg Oncology 2008. IVF Assaf Harofeh IVF 1960 .

IVF &

: ( / )

IVF &

2 * - * - - -

IVF & - - , ICD (International Classification of Diseases 9th edition)

IVF &

: , -- , .

IVF & IVF ()

SIR ( 1 ) , .

IVF &

SIR : - , - (, ) - ( / ) - - ( )

IVF &

Poisson , IVF.

IVF & 3.375 IVF Assaf. Harofeh. 9 1986 31 . 2003 - IVF 3,15 2.39 (1-18 ) 1088 1-3 1077 4 801 4-6 316 7

IVF &

32.15,7 (18-45) Follow-up 8,1 4,3 (1.0 18,7 ) Follow-up 35 24,8 .

K & I M (ORIGINAL REPORT)

Chemotherapy for Breast Cancer during Pregnancy: An 18 year Experience From Five London Teaching Hospitals Alistair Rung, Ian Smith, Alison Jovies, Catherine Shannon et al Journal of Clinical Oncology 23 (18):4192-4197, 2005

Chemotherapy for Breast Carcinoma during pregnancy: A French National Survey. PL Giacolone, F. Fallarque, P. Benos Cancer 86: 2266 2272, 1999

Management of breast cancer during pregnancy using a standardized protocol (MD Anderson) DL Berry, RL Theriault, FA Holmes et al Journal of Clinical Oncology 17: 855 861, 1999

& , . , -,

() .

99 (< 2 .) Blue Dye . ESMO Guidelines Working Group Ann Oncol 21 Suppl 5:266-273, 2010

&

XHMEIO . Early Breast Cancer Trialists, Lancet 352:930-942, 1998

&

() , . , , & .

, , .

Ring et al J Clin Oncol 23(18) 4192-4197

&

H 1 (). 2 & 3 , .

ESMO Guidelines Working Group Ann Oncol 21 Suppl 5:266-273, 2010

& E 1 Nicholson J Obstet Gynaecol Br Commonw 75:307-312, 19681 Royal Marsden2 French National Survey 1 3 Giacalone PL et al Cancer 86:2266-2276,19991 MD Anderson Gwyn et al Proc.Am Soc Clin Oncol 20 (18b) 2001

&

1 .

Berry et al J C Oncol 17: 855 861, 1999 Giacalone et al Cancer 86:2266-2276, 1999 Nicholson J Obstet Gynaecol Br Commonw 75:307-312, 1968

40,5 ( 7 159 ) 67% 63%